Strong Correlation Between mRNA Expression Levels of HIF-2α, VEGFR1, VEGFR2 and MMP2 in Laryngeal Carcinoma

被引:5
|
作者
Popov, Todor M. [1 ]
Stancheva, G. [2 ]
Goranova, T. E. [2 ]
Rangachev, J. [1 ]
Konov, D. [1 ]
Todorov, S. [1 ]
Stoyanov, O. [1 ]
Kaneva, R. P. [2 ]
Popova, D. [1 ]
机构
[1] Med Univ Sofia, Dept ENT, Blvd Han Pagan 1, BG-1680 Sofia, Bulgaria
[2] Med Univ Sofia, Mol Med Ctr, Sofia, Bulgaria
关键词
HIF-1; alpha; HIF-2; VEGFR1; VEGFR2; MMP2; Flt-1; Flk-1; Laryngeal carcinoma; ENDOTHELIAL GROWTH-FACTOR; VASCULAR ENDOTHELIUM; TRANSCRIPTION FACTOR; TYROSINE KINASE; RECEPTOR; ETS-1; ANGIOGENESIS; HYPOXIA; BINDING; TISSUE;
D O I
10.1007/s12253-016-0059-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The hypoxia that arises due to the rapid proliferation of tumor cells is a fundamental driving force for the canonical pathway of neovascularization. In the current study we report a very strong correlation between mRNA expression levels of HIF-2 alpha (but not HIF-1 alpha), VEGFR-1, VEGFR-2 and MMP2 in ex vivo samples from laryngeal carcinoma. Sixty-three samples from patients with histopathologically verified carcinoma of the larynx were examined in this study. Total RNA was isolated from both normal and tumor fresh frozen tissues of each patient and real-time quantitative PCR reactions were performed. The mRNA expression levels of HIF-1 alpha, HIF-2 alpha, VEGFR1, VEGFR2 and MMP2 were acquired. We found strong positive correlations between mRNA expression levels of HIF-2 alpha and VEGFR-1, r (s) (98) = .671, p < .0005; HIF-2 alpha and VEGFR-2, r (s) (98) = .742, p < .0005; HIF-2 alpha and MMP2, r (s) (98) = .566, p < .0005; VEGFR-1 and VEGFR-2, r (s) (98) = .791, p < .0005; VEGFR-1 and MMP2, r (s) (98) = .709, p < .0005; VEGFR-2 and MMP2, r (s) (98) = .793, p < .0005. Our results provide evidence for the regulatory connection between HIF-2 alpha and VEGFR-1, VEGFR-2 and MMP2 in the light of ETS1/ HIF-2 alpha regulatory axis on a non-in-vitro level in carcinoma tissue, uncover some of the differences between the homologues HIF-1 alpha and HIF-2 alpha and round up and support the results from different experimental models in this field.
引用
收藏
页码:741 / 746
页数:6
相关论文
共 50 条
  • [1] MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma
    Kinget, Lisa
    Roussel, Eduard
    Verbiest, Annelies
    Albersen, Maarten
    Rodriguez-Antona, Cristina
    Grana-Castro, Osvaldo
    Inglada-Perez, Lucia
    Zucman-Rossi, Jessica
    Couchy, Gabrielle
    Job, Sylvie
    de Reynies, Aurelien
    Laenen, Annouschka
    Baldewijns, Marcella
    Beuselinck, Benoit
    CANCERS, 2021, 13 (12)
  • [2] VEGF, VEGFR1, and VEGFR2 expression in melanoma
    Mehnert, J. M.
    McCarthy, M. M.
    Aziz, S. A.
    Sznol, M.
    Flaherty, K. T.
    Camp, R. L.
    Rimm, D. L.
    Kluger, H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] VEGFR1 and VEGFR2 immunohistochemical expression in oral squamous cell carcinoma: a morphometric study
    Stinga, A. C.
    Margaritescu, Otilia
    Stinga, Alina Simona
    Pirici, D.
    Ciurea, Raluca
    Bunget, Adina
    Cruce, M.
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2011, 52 (04): : 1269 - 1275
  • [4] VEGFR1 and VEGFR2 in Alzheimer's Disease
    Harris, Rachel
    Miners, James Scott
    Allen, Shelley
    Love, Seth
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 61 (02) : 741 - 752
  • [5] MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2
    Ghosh, Alip
    Dasgupta, Debanjali
    Ghosh, Amit
    Roychoudhury, Shrabasti
    Kumar, Dhiraj
    Gorain, Mahadeo
    Butti, Ramesh
    Datta, Simanti
    Agarwal, Shaleen
    Gupta, Subash
    Dhali, Gopal Krishna
    Chowdhury, Abhijit
    Schmittgen, Thomas D.
    Kundu, Gopal C.
    Banerjee, Soma
    CELL DEATH & DISEASE, 2017, 8 : e2706 - e2706
  • [6] MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2
    Alip Ghosh
    Debanjali Dasgupta
    Amit Ghosh
    Shrabasti Roychoudhury
    Dhiraj Kumar
    Mahadeo Gorain
    Ramesh Butti
    Simanti Datta
    Shaleen Agarwal
    Subash Gupta
    Gopal Krishna Dhali
    Abhijit Chowdhury
    Thomas D Schmittgen
    Gopal C Kundu
    Soma Banerjee
    Cell Death & Disease, 2017, 8 : e2706 - e2706
  • [7] Analysis of VEGF-A/VEGFR1/VEGFR2 gene expression in patients with myelodysplastic syndrome
    Kalitin, N. N.
    Dudina, G. A.
    Semochkin, S. V.
    Karamysheva, A. F.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (07): : 39 - 44
  • [8] Expression of VEGF and Its receptors VEGFR1/VEGFR2 Is Associated with Invasiveness of Bladder Cancer
    Kopparapu, Pradeep Kumar
    Boorjian, Stephen A.
    Robinson, Brian D.
    Downes, Martin
    Gudas, Lorraine J.
    Mongan, Nigel P.
    Persson, Jenny L.
    ANTICANCER RESEARCH, 2013, 33 (06) : 2381 - 2390
  • [9] Activation of VEGFR1 potentiates the activity of the VEGFR2: A model for a biological transistor
    Waltenberger, J
    Kranz, A
    Kroll, J
    Kliche, S
    Mayr, U
    Meyer, N
    Autiero, M
    Conway, E
    Dehio, C
    Collen, D
    Carmeliet, P
    CIRCULATION, 2001, 104 (17) : 140 - 140
  • [10] Suppression of migratory and metastatic pathways via blocking VEGFR1 and VEGFR2
    Sadremomtaz, Afsaneh
    Kobarfard, Farzad
    Mansouri, Kamran
    Mirzanejad, Laleh
    Asghari, S. Mohsen
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2018, 38 (5-6) : 432 - 441